Topoisomerase I as a Biomarker: Detection of Activity at the Single Molecule Level
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Topoisomerase I as a Biomarker: Detection of Activity at the Single Molecule Level
Authors
Keywords
-
Journal
SENSORS
Volume 14, Issue 1, Pages 1195-1207
Publisher
MDPI AG
Online
2014-01-13
DOI
10.3390/s140101195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-time detection of TDP1 activity using a fluorophore–quencher coupled DNA-biosensor
- (2013) Pia W. Jensen et al. BIOSENSORS & BIOELECTRONICS
- A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer
- (2013) Iben Kümler et al. BREAST CANCER RESEARCH AND TREATMENT
- CPT-11 as a second-line treatment for patients with advanced/metastatic gastric cancer who failed S-1 (CCOG0702)
- (2013) Yoshinari Mochizuki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DNA repair mechanisms in dividing and non-dividing cells
- (2013) Teruaki Iyama et al. DNA REPAIR
- Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort
- (2013) David Hersi Smith et al. PLoS One
- Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer
- (2013) Sune Boris Nygård et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- CK2-Mediated Hyperphosphorylation of Topoisomerase I Targets Serine 506, Enhances Topoisomerase I–DNA Binding, and Increases Cellular Camptothecin Sensitivity
- (2012) Keya Bandyopadhyay et al. PLoS One
- Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition
- (2011) Paola Perego et al. BIOCHEMICAL PHARMACOLOGY
- A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer
- (2011) Leora Horn et al. Clinical Lung Cancer
- Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
- (2011) R. Wendel Naumann et al. DRUGS
- Oxaliplatin: a review of approved uses
- (2011) Alexander Stein et al. EXPERT OPINION ON PHARMACOTHERAPY
- Topoisomerase I expression in tumors as a biological marker for CPT-11 chemosensitivity in patients with colorectal cancer
- (2011) Masahide Ikeguchi et al. SURGERY TODAY
- Irinotecan Plus Bolus/Infusional 5-Fluorouracil and Leucovorin in Patients With Pretreated Advanced Pancreatic Carcinoma
- (2010) Vittorio Gebbia et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Protein Kinase CK2 Is a Central Regulator of Topoisomerase I Hyperphosphorylation and Camptothecin Sensitivity in Cancer Cell Lines
- (2010) Keya Bandyopadhyay et al. BIOCHEMISTRY
- Topotecan for relapsed small cell lung cancer: A systematic review and economic evaluation
- (2010) Debbie Hartwell et al. CANCER TREATMENT REVIEWS
- Review role of topotecan in gynaecological cancers: Current indications and perspectives
- (2009) Domenica Lorusso et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Single-Molecule Detection of Human Topoisomerase I Cleavage−Ligation Activity
- (2008) Magnus Stougaard et al. ACS Nano
- Mutations in topoisomerase I as a self-resistance mechanism coevolved with the production of the anticancer alkaloid camptothecin in plants
- (2008) S. Sirikantaramas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now